Top compounds associated with response to OR4D5


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC 0.003 1
mRNA Doxorubicin GDSC1000 pan-cancer AAC 0.002 1
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.0018 1
mRNA YL54 CTRPv2 pan-cancer AAC 0.0021 1
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.002 1
mRNA PI-103 GDSC1000 pan-cancer AAC -0.0016 1
mRNA KU-0063794 CTRPv2 pan-cancer AAC 0.0018 1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0017 1
mRNA BMS-708163 GDSC1000 pan-cancer AAC -0.0017 1
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0017 1
Download CSV